Cryoport Reports Second Quarter 2024 Financial Results PR Newswire NASHVILLE, Tenn., Aug. 6, 2024 Revenue improved sequentially across all businessesCommercial Cell & Gene Therapy revenue...
Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes PR Newswire NASHVILLE, Tenn., Aug. 6, 2024 $200 million repurchase program...
Cryoport to Report Second Quarter 2024 Financial Results on August 6, 2024 PR Newswire NASHVILLE, Tenn., July 23, 2024 NASHVILLE, Tenn., July 23, 2024 /PRNewswire/ -- Cryoport, Inc. (Nasdaq:...
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies PR Newswire NASHVILLE, Tenn. and YOKOHAMA, Japan, June 20, 2024 Partnership...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.